InspireMD Announces Presentation of Positive One-Year Follow-up Results From the C-Guardians U.S. Investigational Device Exemption (Ide) Clinical Trial of Cguard at Linc 2024
InspireMD 宣佈在 Linc 2024 上公佈 Cguard 的 C-Guardians 美國研究設備豁免 (Ide) 臨床試驗的爲期一年的積極隨訪結果